Board Change • May 20
Less than half of directors are independent There are 7 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 7 new directors. No experienced directors. No highly experienced directors. 1 independent director (6 non-independent directors). CEO & Chairman Ethan Shen is the most experienced director on the board, commencing their role in 2024. Independent Director Jerry Lee was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Announcement • Jan 21
YD Bio Limited Announces Committee Changes, Effective January 16, 2026 On January 16, 2026, the Board of Directors of YD Bio Limited approved the appointment of Dr. Chang as Chairman of the Compensation Committee and as a member of the Company’s Audit Committee and Nominating and Corporate Governance Committee, effective January 16, 2026. Additionally, on January 16, 2026, the Board approved the appointment of Dr. Lu as Chairman of the Nominating and Corporate Governance Committee and as a member of the Company’s Audit Committee and Compensation Committee, effective January 16, 2026. Announcement • Jan 16
YD Bio Limited Announces Directorate Changes On January 16, 2026, YD Bio Ltd. announced that YD Biopharma Holding Limited and EG Biomed Limited, two stockholders of the Company whose combined holdings constitute a majority of the Company's voting rights, delivered a shareholders' written consent to the Company's registered office pursuant to the Company's governing documents and the applicable laws of the Cayman Islands. According to the Written Consent, four members of the Company's Board of Directors, Joe Douglas Ramsey, Albert Scott McLelland, Michaela Ann Griggs and Janet Hall, were removed as directors effective December 30, 2025, and two new directors, Dr. Kochi Chang and Dr. Shao-Da Lu were elected to the Board effective December 30, 2025. Dr. Kochi Chang has served as a Member of the Advisory Committee at the Intelligent Computing Research Laboratory, California State University of Fullerton, a nonprofit research institution since May 2022. Previously, he was the Director of the Prosthetics Division at Dentsply International, a for-profit manufacturer of medical devices from June 2006 to August 2013. He co-founded and has served as the Chairman and CEO of Prident International Inc. in California since January 2003. Dr. Chang earned his Bachelor of Dentistry degree from the School of Dentistry at Taipei Medical University in Taiwan. Dr. Shao-Da Lu has served as the Director at L Shao-Da Holistic Health Clinic since October 1992. He has served as the Deputy Secretary-General at the National Federation of Medical Doctors' Associations, Republic of China since August 2017. From September 1983 to August 1987, he worked as a specialist in internal medicine at Linkou Chang Gung Memorial Hospital. From September 1981 to August 1982, he was a pediatrician at the Taipei Women and Children's Hospital. He also holds management and directorship positions at several medical professional associations. Dr. Lu earned his M.D. from China Medical University, College of Medicine. 
